Thaher Pelaseyed 10/2/24 Thaher Pelaseyed 10/2/24

MucoLife Therapeutics CEO, Thaher Pelaseyed, to present breakthrough COPD treatment at BioNTX iC³ Summit in Arlington, Texas

MucoLife Therapeutics secures investment and partners with US-based Health Wildcatters Accelerator to advance a first-in-class treatment for COPD

MucoLife Therapeutics announces a partnership with the US-based life science accelerator Health Wildcatters.

Launch

MucoLife Therapeutics, a pioneering biotechnology company, announces its official launch today. The company emerges with a groundbreaking mission: to revolutionize mucus management and empower people worldwide to breathe easier and live healthier lives.